IL-2 gene knockout affects T lymphocyte trafficking and the microglial response to regenerating facial motor neurons

Journal of Neuroimmunology

Volumn 134, Issue 1-2, 2003, Pages 95-103

  Petitto, John M ^a,b   Huang, Zhi ^a   Lo, Jeannette ^a   Streit, Wolfgang J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

MHC class II; Microglia; Neuronal injury; Regeneration; T lymphocyte chemotaxis

Indexed keywords

CD11 ANTIGEN; INTERLEUKIN 2;

ALLELE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FACIAL NERVE; GENE EXPRESSION; KNOCKOUT GENE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MICROGLIA; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; FACIAL NERVE; FACIAL NERVE INJURIES; FEMALE; GLIOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; LYMPHOCYTE COUNT; MALE; MICE; MICE, KNOCKOUT; MICE, SCID; MICROGLIA; MOTOR NEURONS; MUTATION; NERVE REGENERATION; RETROGRADE DEGENERATION; T-LYMPHOCYTES;

EID: 0037221415     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00422-8     Document Type: Article

References (47)

1. Aloisi F., Serafini B., Adorini L. Glia-T cell dialogue. J. Neuroimmunol. 107:2000;111-117.
2. Araujo D.M., Lapchak P.A. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience. 61:1994;745-754.
3. Araujo D.M., Lapchak P.A., Collier B., Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 498:1989;257-266.
4. Awatsuji H., Furukawa Y., Nakajima M., Furukawa S., Hayashi K. Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J. Neurosci. Res. 35:1993;305-311.
5. Barouch R., Appel E., Kazimirsky G., Braun A., Renz H., Brodie C. Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes. J. Neuroimmunol. 103:2000;112-121.
6. Bosma G.C., Custer R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature. 301:1983;527-530.
7. Civallero M., Barni S., Nano R., Capelli E. Dendritic cells and interleukin-2: cytochemical and ultrastructural study. Histol. Histopathol. 15:2000;1077-1085.
8. Cohen I.R., Schwartz M. Autoimmune maintenance and neuroprotection of the central nervous system. J. Neuroimmunol. 100:1999;111-114.
9. Eitan S., Schwartz M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science. 261:1993;106-108.
10. Eizenberg O., Faber-Elman A., Lotan M., Schwartz M. Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J. Neurochem. 64:1995;1928-1936.
11. Espinoza-Delgado I., Bosco M.C., Musso T., Gusella G.L., Longo D.L., Varesio L. Interleukin-2 and human monocyte activation. J. Leukoc. Biol. 57:1995;13-19.
12. Ford A.L., Foulcher E., Lemckert F.A., Sedgwick J.D. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1996;1737-1745.
13. Grassl G., Pummerer C.L., Horak I., Neu N. Induction of autoimmune myocarditis in interleukin-2-deficient mice. Circulation. 95:1997;1773-1776.
14. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20:2000;5283-5291.
15. Hanisch U.K., Neuhaus J., Rowe W., Van Rossum D., Moller T., Kettenmann H., Quirion R. Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience. 79:1997;799-818.
16. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet. 355:2000;286-287.
17. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20:2000;6421-6430.
18. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:1988;290-292.
19. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:1991;254-260.
20. Hirschberg D., Moalem G., He J., Mor F., Cohen I., Schwartz M. Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J. Neuroimmunol. 89:1998;88-96.
21. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 107:2000;161-166.
22. Horak I., Lohler J., Ma A., Smith K.A. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148:1995;35-44.
23. Irani D.N., Lin K.I., Griffin D.E. Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. 158:1997;2318-2326.
24. Katsuki M., Kimura M., Ohta M., Otani H., Tanaka O., Yamamoto T., Nozawa-Kimura S., Yokoyama M., Nomura T., Habu S. Lymphocyte infiltration into cerebellum in transgenic mice carrying human IL-2 gene. Int. Immunol. 1:1989;214-218.
25. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience. 44:1991;173-184.
26. Lomen-Hoerth C., Shooter E.M. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J. Neurochem. 64:1995;1780-1789.
27. Mennicken F., Quirion R. Interleukin-2 increases choline acetyltransferase activity in septal-cell cultures. Synapse. 26:1997;175-183.
28. Möller J.C., Klein M.A., Haas S., Jones L.L., Kreutzberg G.W., Raivich G. Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia. 17:1996;121-132.
29. Nemni R., Iannaccone S., Quattrini A., Smirne S., Sessa M., Lodi M., Erminio C., Canal N. Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice. Brain Res. 591:1992;248-252.
30. Nieto-Sampedro M., Chandy K.G. Interleukin-2-like activity in injured rat brain. Neurochem. Res. 12:1987;723-727.
31. Olsson T., Diener P., Ljungdahl A., Hojeberg B., van der Meide P.H., Kristensson K. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity. 13:1992;117-126.
32. Petitto J.M., Huang Z. Cloning the full-length IL-2/15 receptor-beta cDNA sequence from mouse brain: evidence of enrichment in hippocampal formation neurons. Regul. Pept. 98:2001;77-87.
33. Petitto J.M., Streit W.J., Huang Z., Butfiloski E., Schiffenbauer J. Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice. Neurosci. Lett. 285:2000;66-70.
34. Petitto J.M., Huang Z., Hartemink D.A., Beck R. IL-2/15 receptor-beta gene deletion alters neurobehavioral performance. Brain Res. 929:2002;218-225.
35. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., Kreutzberg G.W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J. Neurosci. 18:1998;5804-5816.
36. + T cells. Eur. J. Immunol. 25:1995;3053-3059.
37. Sawada M., Suzumura A., Marunouchi T. Induction of functional interleukin-2 receptor in mouse microglia. J. Neurochem. 64:1995;1973-1979.
38. Schori H., Yoles E., Schwartz M. T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system. J. Neuroimmunol. 119:2001;199-204.
39. Schorle H., Holtschke T., Hunig T., Schimpl A., Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 352:1991;621-624.
40. Schwartz M., Cohen I.R. Autoimmunity can benefit self-maintenance. Immunol. Today. 21:2000;265-268.
41. Schwartz M., Cohen I., Lazarov-Spiegler O., Moalem G., Yoles E. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J. Mol. Med. 77:1999;713-717.
42. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J. Neurosci. 19:1999;RC7.
43. Serpe C.J., Sanders V.M., Jones K.J. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J. Neurosci. Res. 62:2000;273-278.
44. Streit W.J., Graeber M.B., Kreutzberg G.W. Functional plasticity of microglia: a review. Glia. 1:1988;301-307.
45. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 57:1999;563-581.
46. Streit W.J., Hurley S.D., McGraw T.S., Semple-Rowland S.L. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J. Neurosci. Res. 61:2000;10-20.
47. Wahl S.M., McCartney-Francis N., Hunt D.A., Smith P.D., Wahl L.M., Katona I.M. Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J. Immunol. 139:1987;1342-1347.